TCR Convergence in Individuals Treated With Immune Checkpoint Inhibition for Cancer is a research paper published in Frontiers in Immunology (2020). On theSindex it has a DataRank of 0. It has been cited 58 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: R01 CA194511
NCI NIH HHS
Grant: R01 CA223484
NCI NIH HHS
Grant: U01 CA233100
National Institutes of Health
Grant: 5R01CA223484-02
Determinants of prostate cancer sensitivity to PD-1 blockade
National Institutes of Health
Grant: 1U01CA233100-01
Molecular and immune drivers of immunotherapy responsiveness in prostate cancer
National Institutes of Health
Grant: 5R01CA194511-04
Immunotherapy of human bladder cancer
National Institutes of Health
FWCI
2.22
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals